References
Mazzaferro V. Squaring the circle of selection nd allocation in liver transplantation for HCC : an adaptive approach. Hepatology. 2016;63:1707–17.
Halazun, et al. Standing the test of time : outcomes of a decade prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology. 2014;60:1957–62.
Belli LS, Berenguer M, Cortesi B, et al. Impact of direct anti-viral agents on inactivation /de-listing of liver transplant candidates listed for decompensated C cirrhosis : a European study. J Hepatol.
Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma : clinical features and perspectives. Gut. 2014;47:844–55.
Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma : outcomes and novel surgical approaches. Nature Reviews/Gastroenterology and Hepatology. 2017;2017:1–15.
Yao FY, Mehta N, Flemming J, et al. Down staging of hepatocellular cancer before liver transplant: long-term outcome compored to tumors within Milan criteria. Hepatology. 2015;61:1968–77.
Piscaglia F, Svegliati-Baroni G, Burchetti A, et al. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease : a multicenter prospective study. Hepatology. 2016;63:827–38.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akkız, H. New Paradigm: Adaptive Approach. J Gastrointest Canc 48, 219–221 (2017). https://doi.org/10.1007/s12029-017-9956-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-017-9956-3